Squamous
Pancreatic progenitor
Aberrantly differentiated endocrine exocrine (ADEX)
Immunogenic The immunogenic kind could potentially respond to types of cancer immunotherapy, in which the immune system is re-engineered to recognize and attack cancer cells. "The findings of this research are incredibly exciting for anyone affected by pancreatic cancer, as they should mean that in the future the right patients can be given the right treatment at the right time,” says Leanne Reynolds, head of research at the charity Pancreatic Cancer UK. “This is crucial for people with pancreatic cancer, because the disease is difficult to diagnose, is often diagnosed terribly late, and just 4% of people live for 5 years or more after diagnosis. "If we can predict more accurately which treatment would be most effective for each patient, we can ensure patients have the best chance of living for as long as possible, as well as possible." Source: © 2016 WebMD, LLC. All rights reserved.
top of page
Recent Posts
See AllHopkINNS Helps was created after a conversation I had with a pancreatic cancer patient named David Sokoloff. David had a successful whipple surgery at Johns Hopkins Hospital and was doing great until
00
Surgical site infections are common, especially in high risk patients following the Whipple procedure. Negative pressure wound therapy (or wound vacs) can lower the risk of surgical site infections in
20
bottom of page